Golden has been acquired by ComplyAdvantage.Read about it here ⟶

NBE Therapeutics

NBE Therapeutics is a Basel-based biotechnology company specializing in oncology. The company has developed an antibody drug conjugate platform targeting solid tumors.

Overview Structured Data Issues Contributors Activity

nbe-therapeutics.com

Is a

Organization

Company

Company attributes

Industry

Biomedical engineering

Internal medicine

Healthcare

...

Location

Switzerland

Basel

Pitchbook URL

pitchbook.com/profiles.../64197-28

Full Address

Hochbergstrasse 60C, Technology Park Basel AG, Basel, CH0

Investors

PPF (company)

Boehringer Ingelheim

Total Funding Amount (USD)

42,000,000

Latest Funding Round Date

2020

Also Known As

NBE-Therapeutiecs

Latest Funding Type

Series C

Patents Assigned (Count)

Country

Switzerland

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

22,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like NBE Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API